The Translational Medicine Alliance was formed in March 2007 by the Kauffman Foundation, Adjuvant Global Advisors, and the Center for Emerging Technologies to address what many perceive to be a national and international leadership vacuum in translational medicine. Despite the growing sophistication and promise of healthcare technology research, fewer and fewer breakthrough ideas are finding their way out of research institutions and into the hands of experienced clinicians and medical product development teams. Patients suffer as a result because promising research and innovation is not being translated into new treatments.

This is one of the reasons for the rapid decline in new drug approvals at the FDA. This leadership vacuum can only be corrected if all of the major stakeholder groups involved in translational medicine pledge to work together. This will involve the participation of the medical product development industry, the growing philanthropic and research nonprofit communities, academia, the investment community, and the federal government.

The Translational Medicine Alliance was formed to tap into the best ideas of thought leaders and develop an integrated strategy to support and advance the most promising technologies.

2009 Event — Watch video clips and view presentations from the Translational Medicine Alliance Forum 2009, May 13 - 15, 2009, in Philadelphia, PA.

2007 Event — Download the Translational Medicine Forum 2007 White Paper and read more about our inaugural event held in 2007 in St. Louis, MO.